Sanofi ADR (SNY)
NASDAQ · Healthcare · Drug Manufacturers - General
Sanofi ADR is a Healthcare company with a market capitalization of $102.81B and a trailing P/E ratio of 19.1.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025 · in EUR
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 23, 2026 | $1.10 | $1.03 | +6.8% |
| Q4 2025 | January 29, 2026 | $0.91 | $0.85 | +7.1% |
| Q3 2025 | October 24, 2025 | $1.34 | $1.28 | +4.7% |
| Q2 2025 | July 31, 2025 | $0.91 | $1.00 | -9.0% |
| Q1 2025 | April 24, 2025 | $1.02 | $0.95 | +7.4% |
| Q4 2024 | January 30, 2025 | $0.68 | $0.74 | -8.1% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Sanofi ADR's market cap?
As of June 29, 2026, Sanofi ADR (SNY) has a market capitalization of $102.81B.
What is Sanofi ADR's P/E ratio?
Sanofi ADR trades at a trailing price-to-earnings (P/E) ratio of 19.1. Its forward P/E is 8.8.
Does Sanofi ADR pay a dividend?
Sanofi ADR does not currently pay a dividend.
What sector is SNY in?
Sanofi ADR is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was Sanofi ADR's revenue?
In its latest reported fiscal year (ending December 31, 2025), Sanofi ADR reported revenue of 46.72B EUR and net income of 7.81B EUR.
Ask your own questions about SNY
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.